Ultragenyx to Participate at Investor Conferences in March

Rhea-AI Summary

Ultragenyx (NASDAQ: RARE) will participate in three investor conferences in March 2026 with Eric Crombez, M.D., Chief Medical Officer, delivering fireside chats and hosting 1x1 meetings.

Events: Cowen Healthcare Conference on March 2 in Boston; Barclays Global Healthcare on March 10 in Miami; Leerink Partners Global Biopharma on March 11 in Miami. Live and archived webcasts will be available at the company investor events page.

News Market Reaction – RARE

+1.07%

5 alerts

+1.07% Session close to close

$2.30B Market Cap

0.0x Rel. Volume

In the Feb 24 session, RARE gained 1.07%, reflecting a mild positive market reaction. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NOVATO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced participation in three upcoming investor conferences.

46^th Annual Cowen Healthcare Conference (Boston, MA)

• Monday, March 2, 2026, Eric Crombez, M.D., Chief Medical Officer, will participate in a fireside chat and host 1x1 meetings.
  
  

Barclays 28^th Annual Global Healthcare Conference (Miami, FL)

• Tuesday, March 10, 2026, Eric Crombez will participate in a fireside chat and host 1x1 meetings.
  
  

Leerink Partners Global Biopharma Conference (Miami, FL)

• Wednesday, March 11, 2026, Eric Crombez will participate in a fireside chat and host 1x1 meetings.
  
  

The live and archived webcast of the fireside chat will be accessible from the company’s website at https://ir.ultragenyx.com/events-presentations.

About Ultragenyx

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.

Contacts – Ultragenyx
Investors
Joshua Higa
ir@ultragenyx.com

FAQ

When will Ultragenyx (RARE) present at the Cowen Healthcare Conference in 2026?

Ultragenyx will present at Cowen on March 2, 2026 with a fireside chat and 1x1 meetings. According to the company, Eric Crombez, M.D., Chief Medical Officer, will represent Ultragenyx and participate in the fireside chat and investor meetings that day.

What is Ultragenyx (RARE) scheduled to do at the Barclays Global Healthcare Conference?

Ultragenyx is scheduled for a fireside chat and 1x1 meetings on March 10, 2026 at Barclays in Miami. According to the company, Eric Crombez will lead the discussion and meet with investors for follow-up one-on-one sessions that day.

Where and when will Ultragenyx (RARE) appear at the Leerink Partners Global Biopharma Conference?

Ultragenyx will appear at Leerink on March 11, 2026 in Miami for a fireside chat and 1x1 meetings. According to the company, Eric Crombez will participate in the scheduled fireside chat and host investor meetings that day.

How can investors watch Ultragenyx (RARE) fireside chats from the March 2026 conferences?

Investors can watch live and archived webcasts via the company investor events page at ir.ultragenyx.com/events-presentations. According to the company, both live streaming and archived recordings of the fireside chats will be accessible there.

Who will represent Ultragenyx (RARE) at the March 2026 investor conferences?

Eric Crombez, M.D., Chief Medical Officer, will represent Ultragenyx at all three March 2026 conferences and host 1x1 meetings. According to the company, he will participate in fireside chats and investor sessions at each event.

Which dates should investors save for Ultragenyx (RARE) March 2026 conference appearances?

Save March 2, March 10, and March 11, 2026 for Ultragenyx conference appearances in Boston and Miami. According to the company, those dates correspond to Cowen, Barclays, and Leerink conference events respectively.